Purchase Order 75D30123P17136
Award Date 7/6/23
Potential Completion Date 7/5/24
Potential Value $242K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $75,262.76, is for the supply of MiSeq Reagent Kits to support the agency's genomic sequencing and analysis capabilities. This award does not have a set-aside designation. Illumina has a history of providing sequencing systems, reagents, and related services to...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $20,400.00, is for the provision of ILLUMINA - AMPLISEQ products and services, with a period of performance through September 30, 2024. The contract has no set-aside designation. Illumina has a history of providing sequencing equipment and consumables to support...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $247,057.60, is for the delivery of ISEQ REAGENTS with a period of performance through September 30, 2023. Illumina has previously been awarded prime federal contracts and subcontracts by agencies such as the National Institutes of Health, Department of...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for MiSeq and MiniSeq sequencing systems and reagents, with a ceiling value of $132,300.66 and a period of performance through August 31, 2016. This contract does not have a set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to federal...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $75,775.80 contract is for the provision of Illumina MiSeq reagents to support the agency's genomic sequencing and analysis needs. The contract has no set-aside designation. Illumina has previously provided a range of sequencing systems, consumables, and services to support...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,020.00 contract is for the provision of lab supplies, with a period of performance through July 29, 2023. There is no set-aside designation indicated. Illumina has previously received prime federal contract awards and subcontracts from agencies like the National...
- This is a firm fixed price contract award to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The contract provides $97,788.84 for Illumina reagent kits to support genomic sequencing and analysis. The award does not have a set-aside designation. Illumina has previously received prime federal contracts and subcontracts from agencies like the NIH, USDA, and VA for a range of...
- This is a firm fixed price purchase order awarded by the U.S. Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for a MiSeq System. The $131,966.00 contract has a period of performance ending on July 31, 2016. Illumina has provided sequencing systems and services to various federal agencies in the past, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of MiSeq sequencer and MiniSeq system equipment. The total ceiling value of the contract is $144,985.50, with a period of performance ending on May 9, 2016. Illumina is a manufacturer of genetic and genomic analysis instruments and reagents, and has previously provided sequencing systems and related products to support research and diagnostics at various...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $35,041.35, is for the delivery of DNA reagents with a completion date of September 20, 2024. Illumina has a history of providing sequencing systems, reagents, and bioinformatics products to support genomic research and diagnostics across various federal...